Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.

Villa A, Celentano A, Glurich I, Borgnakke WS, Jensen SB, Peterson DE, Delli K, Ojeda D, Vissink A, Farah CS.

Oral Dis. 2019 Jun;25 Suppl 1:64-78. doi: 10.1111/odi.13087.

PMID:
31140698
2.

World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome-A systematic review.

Delli K, Villa A, Farah CS, Celentano A, Ojeda D, Peterson D, Jensen SB, Glurich I, Vissink A.

Oral Dis. 2019 Jun;25 Suppl 1:49-63. doi: 10.1111/odi.13041.

PMID:
30663837
3.

Patient Awareness of Association of Diabetes and Periodontal Disease.

Shimpi N, Glurich I, Schroeder D, Katrak C, Chyou PH, Acharya A.

Health Promot Pract. 2018 Sep 21:1524839918801909. doi: 10.1177/1524839918801909. [Epub ahead of print]

PMID:
30238811
4.

Patient awareness/knowledge towards oral cancer: a cross-sectional survey.

Shimpi N, Jethwani M, Bharatkumar A, Chyou PH, Glurich I, Acharya A.

BMC Oral Health. 2018 May 15;18(1):86. doi: 10.1186/s12903-018-0539-x.

5.

Screening for dysglycaemia in dental primary care practice settings: systematic review of the evidence.

Glurich I, Bartkowiak B, Berg RL, Acharya A.

Int Dent J. 2018 Dec;68(6):369-377. doi: 10.1111/idj.12405. Epub 2018 May 8.

PMID:
29740815
6.

Tobacco use status from clinical notes using Natural Language Processing and rule based algorithm.

Hegde H, Shimpi N, Glurich I, Acharya A.

Technol Health Care. 2018;26(3):445-456. doi: 10.3233/THC-171127.

PMID:
29614708
7.

Need for diagnostic-centric care in dentistry: A case study from the Marshfield Clinic Health System.

Shimpi N, Ye Z, Koralkar R, Glurich I, Acharya A.

J Am Dent Assoc. 2018 Feb;149(2):122-131. doi: 10.1016/j.adaj.2017.09.030.

8.

Integrating Medical-Dental Care for Diabetic Patients: Qualitative Assessment of Provider Perspectives.

Glurich I, Schwei KM, Lindberg S, Shimpi N, Acharya A.

Health Promot Pract. 2018 Jul;19(4):531-541. doi: 10.1177/1524839917737752. Epub 2017 Oct 26.

9.

Oral and Craniofacial Anomalies of Bardet-Biedl Syndrome: Dental Management in the Context of a Rare Disease.

Panny A, Glurich I, Haws RM, Acharya A.

J Dent Res. 2017 Nov;96(12):1361-1369. doi: 10.1177/0022034517716913. Epub 2017 Jun 29. Review.

10.

Status Update on Translation of Integrated Primary Dental-Medical Care Delivery for Management of Diabetic Patients.

Glurich I, Nycz G, Acharya A.

Clin Med Res. 2017 Jun;15(1-2):21-32. doi: 10.3121/cmr.2017.1348. Epub 2017 Apr 3. Review.

11.

Knowledgeability, Attitude and Behavior of Primary Care Providers Towards Oral Cancer: a Pilot Study.

Shimpi N, Bharatkumar A, Jethwani M, Chyou PH, Glurich I, Blamer J, Acharya A.

J Cancer Educ. 2018 Apr;33(2):359-364. doi: 10.1007/s13187-016-1084-4.

PMID:
27448614
12.

Medical Providers' Oral Health Knowledgeability, Attitudes, and Practice Behaviors: An Opportunity for Interprofessional Collaboration.

Shimpi N, Schroeder D, Kilsdonk J, Chyou PH, Glurich I, Penniman E, Acharya A.

J Evid Based Dent Pract. 2016 Mar;16(1):19-29. doi: 10.1016/j.jebdp.2016.01.002.

PMID:
27132552
13.

Progress in oral personalized medicine: contribution of 'omics'.

Glurich I, Acharya A, Brilliant MH, Shukla SK.

J Oral Microbiol. 2015 Sep 4;7:28223. doi: 10.3402/jom.v7.28223. eCollection 2015.

14.

Type 2 diabetes mellitus, glycemic control, and cancer risk.

Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA.

Eur J Cancer Prev. 2014 Mar;23(2):134-40. doi: 10.1097/CEJ.0b013e3283656394.

PMID:
23962874
15.

Increased risk of colon cancer in men in the pre-diabetes phase.

Onitilo AA, Berg RL, Engel JM, Glurich I, Stankowski RV, Williams G, Doi SA.

PLoS One. 2013 Aug 2;8(8):e70426. doi: 10.1371/journal.pone.0070426. Print 2013.

16.

Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements?

Glurich I, Berg RL, Burmester JK.

Clin Med Res. 2013 Jun;11(2):73-9. doi: 10.3121/cmr.2013.1130. Epub 2013 May 8.

17.

Prostate cancer risk in pre-diabetic men: a matched cohort study.

Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA.

Clin Med Res. 2013 Dec;11(4):201-9. doi: 10.3121/cmr.2013.1160. Epub 2013 May 8.

18.

Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase.

Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA.

Eur J Cancer Prev. 2014 Mar;23(2):76-83. doi: 10.1097/CEJ.0b013e32836162aa.

PMID:
23571511
19.
20.

Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen.

Onitilo AA, Doi SA, Engel JM, Glurich I, Berg R.

Thromb Res. 2013 Jun;131(6):567-8. doi: 10.1016/j.thromres.2013.01.035. Epub 2013 Feb 24. No abstract available.

PMID:
23497923
21.

Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.

Glurich I, Chyou PH, Engel JM, Cross DS, Onitilo AA.

Clin Med Res. 2013 Feb;11(1):16-25. doi: 10.3121/cmr.2012.1101.

22.

Predicting atrial fibrillation and flutter using electronic health records.

Karnik S, Tan SL, Berg B, Glurich I, Zhang J, Vidaillet HJ, Page CD, Chowdhary R.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5562-5. doi: 10.1109/EMBC.2012.6347254.

PMID:
23367189
23.

Consensus guideline adoption for managing postoperative nausea and vomiting.

Myklejord DJ, Yao L, Liang H, Glurich I.

WMJ. 2012 Oct;111(5):207-13; quiz 214.

24.

Diabetes and cancer I: risk, survival, and implications for screening.

Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA.

Cancer Causes Control. 2012 Jun;23(6):967-81. doi: 10.1007/s10552-012-9972-3. Epub 2012 May 3. Review.

25.

Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.

Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA.

Cancer Causes Control. 2012 Jul;23(7):991-1008. doi: 10.1007/s10552-012-9971-4. Epub 2012 Apr 25. Review.

26.

The oral-systemic personalized medicine model at Marshfield Clinic.

Glurich I, Acharya A, Shukla SK, Nycz GR, Brilliant MH.

Oral Dis. 2013 Jan;19(1):1-17. doi: 10.1111/j.1601-0825.2012.01921.x. Epub 2012 Mar 28. Review.

27.

A database of annotated promoters of genes associated with common respiratory and related diseases.

Chowdhary R, Tan SL, Pavesi G, Jin J, Dong D, Mathur SK, Burkart A, Narang V, Glurich I, Raby BA, Weiss ST, Wong L, Liu JS, Bajic VB.

Am J Respir Cell Mol Biol. 2012 Jul;47(1):112-9. doi: 10.1165/rcmb.2011-0419OC. Epub 2012 Mar 1.

PMID:
22383585
28.

Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.

Onitilo AA, Doi SA, Engel JM, Glurich I, Johnson J, Berg R.

Thromb Res. 2012 Jul;130(1):27-31. doi: 10.1016/j.thromres.2011.11.025. Epub 2011 Dec 7.

29.

Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.

Burmester JK, Berg RL, Glurich I, Yale SH, Schmelzer JR, Caldwell MD.

Clin Med Res. 2011 Nov;9(3-4):119-24. doi: 10.3121/cmr.2011.951. Epub 2011 May 11.

30.

A randomized controlled trial of genotype-based Coumadin initiation.

Burmester JK, Berg RL, Yale SH, Rottscheit CM, Glurich IE, Schmelzer JR, Caldwell MD.

Genet Med. 2011 Jun;13(6):509-18. doi: 10.1097/GIM.0b013e31820ad77d.

PMID:
21423021
31.

Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.

Klimant E, Glurich I, Mukesh B, Onitilo AA.

Clin Med Res. 2011 Nov;9(3-4):111-8. doi: 10.3121/cmr.2011.907. Epub 2011 Jan 24.

32.

Research mentor: a web-based resource supporting grantsmanship and scientific publication.

Glurich I, Fleisner M.

Clin Med Res. 2010 Dec;8(3-4):173-5. doi: 10.3121/cmr.2010.950. Epub 2010 Sep 17. Review. No abstract available.

33.

Virchow's contribution to the understanding of thrombosis and cellular biology.

Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH.

Clin Med Res. 2010 Dec;8(3-4):168-72. doi: 10.3121/cmr.2009.866. Epub 2010 Aug 25. No abstract available.

34.

A pilot study of gene/gene and gene/environment interactions in Alzheimer disease.

Ghebranious N, Mukesh B, Giampietro PF, Glurich I, Mickel SF, Waring SC, McCarty CA.

Clin Med Res. 2011 Mar;9(1):17-25. doi: 10.3121/cmr.2010.894. Epub 2010 Aug 3.

35.

The Wisconsin Network for Health Research (WiNHR): a statewide, collaborative, multi-disciplinary, research group.

Bailey H, Agger W, Baumgardner D, Burmester JK, Cisler RA, Evertsen J, Glurich I, Hartman D, Yale SH, DeMets D.

WMJ. 2009 Dec;108(9):453-8.

36.

Association of B-type natriuretic Peptide levels with estimated glomerular filtration rate and congestive heart failure.

Wiley CL, Switzer SP, Berg RL, Glurich I, Dart RA.

Clin Med Res. 2010 Mar;8(1):7-12. doi: 10.3121/cmr.2009.867. Epub 2009 Nov 17.

37.

Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans.

Giampietro PF, Dunwoodie SL, Kusumi K, Pourquié O, Tassy O, Offiah AC, Cornier AS, Alman BA, Blank RD, Raggio CL, Glurich I, Turnpenny PD.

Ann N Y Acad Sci. 2009 Jan;1151:38-67. doi: 10.1111/j.1749-6632.2008.03452.x. Review.

PMID:
19154516
38.

Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.

Onitilo AA, McCarty CA, Wilke RA, Glurich I, Engel JM, Flockhart DA, Nguyen A, Li L, Mi D, Skaar TC, Jin Y.

Breast Cancer Res Treat. 2009 Jun;115(3):643-50. doi: 10.1007/s10549-008-0264-2. Epub 2008 Dec 12.

PMID:
19082882
39.

Understanding the pharmacogenetic approach to warfarin dosing.

Glurich I, Burmester JK, Caldwell MD.

Heart Fail Rev. 2010 May;15(3):239-48. doi: 10.1007/s10741-008-9115-9. Epub 2008 Nov 8. Review.

PMID:
18998206
40.

Molecular diagnosis of vertebral segmentation disorders in humans.

Giampietro PF, Dunwoodie SL, Kusumi K, Pourquié O, Tassy O, Offiah AC, Cornier AS, Alman BA, Blank RD, Raggio CL, Glurich I, Turnpenny PD.

Expert Opin Med Diagn. 2008 Oct;2(10):1107-21. doi: 10.1517/17530059.2.10.1107.

PMID:
23496422
41.

Applying case definition criteria to irritable bowel syndrome.

Yale SH, Musana AK, Kieke A, Hayes J, Glurich I, Chyou PH.

Clin Med Res. 2008 May;6(1):9-16. doi: 10.3121/cmr.2008.788. Review.

42.

A missense T (Brachyury) mutation contributes to vertebral malformations.

Ghebranious N, Blank RD, Raggio CL, Staubli J, McPherson E, Ivacic L, Rasmussen K, Jacobsen FS, Faciszewski T, Burmester JK, Pauli RM, Boachie-Adjei O, Glurich I, Giampietro PF.

J Bone Miner Res. 2008 Oct;23(10):1576-83. doi: 10.1359/jbmr.080503.

43.

CYP4F2 genetic variant alters required warfarin dose.

Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK.

Blood. 2008 Apr 15;111(8):4106-12. doi: 10.1182/blood-2007-11-122010. Epub 2008 Feb 4.

44.

Lack of evidence of WNT3A as a candidate gene for congenital vertebral malformations.

Ghebranious N, Raggio CL, Blank RD, McPherson E, Burmester JK, Ivacic L, Rasmussen K, Kislow J, Glurich I, Jacobsen FS, Faciszewski T, Pauli RM, Boachie-Adjei O, Giampietro PF.

Scoliosis. 2007 Sep 23;2:13.

45.

Evaluation of genetic factors for warfarin dose prediction.

Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH, Vidaillet HJ, Burmester JK.

Clin Med Res. 2007 Mar;5(1):8-16. Erratum in: Clin Med Res. 2007 Jun;5(2):142.

46.

DLL3 as a candidate gene for vertebral malformations.

Giampietro PF, Raggio CL, Reynolds C, Ghebranious N, Burmester JK, Glurich I, Rasmussen K, McPherson E, Pauli RM, Shukla SK, Merchant S, Jacobsen FS, Faciszewski T, Blank RD.

Am J Med Genet A. 2006 Nov 15;140(22):2447-53.

PMID:
17041936
47.

Evaluation of SLC35A3 as a candidate gene for human vertebral malformations.

Ghebranious N, Burmester JK, Glurich I, McPherson E, Ivacic L, Kislow J, Rasmussen K, Kumar V, Raggio CL, Blank RD, Jacobsen FS, Faciszewski T, Womack J, Giampietro PF.

Am J Med Genet A. 2006 Jun 15;140(12):1346-8. No abstract available.

PMID:
16691598
48.
49.

Excessive daytime sleepiness and sleep complaints among children with epilepsy.

Maganti R, Hausman N, Koehn M, Sandok E, Glurich I, Mukesh BN.

Epilepsy Behav. 2006 Feb;8(1):272-7. Epub 2005 Dec 13. Erratum in: Epilepsy Behav. 2006 Aug;9(1):216-7.

PMID:
16352471
50.

Efficacy of the influenza vaccine in patients with malignant lymphoma.

Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, Linneman JG, Reed KD.

Clin Med Res. 2005 Nov;3(4):214-20.

Supplemental Content

Loading ...
Support Center